Cinchocaine - USP
CAS: 85-79-0
Ref. 3D-FC33247
10g | 136,00 € | ||
25g | 184,00 € | ||
50g | 303,00 € | ||
100g | 406,00 € | ||
250g | 542,00 € |
Información del producto
- Dibucaine
- 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
- 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide
- 2-Butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
- 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide
- 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- Cinchocain
- Cinchocaine
- Cinchocaine Base
- Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- Ver más sinónimos
- Cincocainio
- Dermacaine
- Dibucaine (base and/or unspecified salts)
- Dibucaine Free Base Crystalline
- Dibucaine Solution
- Dibucaine Usp
- Dibucaine base
- N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide
- Nsc 159055
- Nupercainal
- Nupercaine
- Percamine
Cinchocaine is a local anesthetic, which is used to relieve pain. Cinchocaine is a member of the amide class of local anesthetics. It has been shown to have neuronal death and mitochondrial membrane potential-inhibiting properties. Cinchocaine also binds to the hydrophobic region of voltage-sensitive potassium channels (Kv1.2), resulting in their closure and preventing action potentials from propagating through the neuron. The optimum concentration for cinchocaine is 0.1% (w/v). The optimal pH range for cinchocaine is 7.0 - 8.0, with a phase transition temperature of 78°C and a melting point of 117°C. Cinchocaine has been shown to be effective in animal models at concentrations as low as 10 µg/mL, with significant therapeutic effects observed at concentrations greater than 50 µg/mL
Propiedades químicas
Consulta técnica sobre: 3D-FC33247 Cinchocaine - USP
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.